独家丨对话王小川：我没觉得委屈

Core Viewpoint - The article discusses the strategic transformation and organizational adjustments of Baichuan Intelligence, led by CEO Wang Xiaochuan, focusing on the shift towards a medical AI model and the importance of non-consensus decisions in the current AI landscape [4][6][8]. Group 1: Organizational Changes - Baichuan Intelligence has undergone significant downsizing, reducing its workforce from 450 to under 200 and simplifying its management structure from 3.6 levels to 2.4 levels [4][6]. - The company aims to retain only those who believe in AI and embrace the medical field, indicating a focus on aligning the team with its core mission [10][16]. Group 2: Strategic Focus - The company has decided to concentrate its efforts on the medical sector, moving away from other areas like finance and entertainment, which were deemed too distracting [8][22]. - Wang Xiaochuan emphasizes the importance of pursuing non-consensus projects, which may be challenging but are essential for innovation and leadership in the industry [9][31]. Group 3: Communication and Leadership - The frequency of internal communication has increased, with Wang personally interviewing new hires to ensure alignment with the company's vision [14][18]. - The leadership style has evolved to be more collaborative, with team leaders empowered to set specific goals while maintaining overall direction [19][20]. Group 4: Market Positioning - Baichuan Intelligence aims to develop a sovereign medical AI model rather than merely providing API services to businesses, indicating a shift towards consumer-oriented solutions [35][40]. - The company recognizes the potential for greater impact in the Chinese market for consumer-facing AI medical products compared to the U.S. [39].